Petco Health and Wellness Company, Inc. (WOOF) Key Metrics
WOOF valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $667.4M
- Enterprise value
- $3.19B
- P/E (TTM)
- 23.3 10-yr median 34.2
- Forward P/E
- 7.0
- PEG ratio
- —
- Price / sales
- 0.1 10-yr median 0.3
- Price / book
- 0.5 10-yr median 1.1
- EV / EBITDA
- 9.8 10-yr median 17.3
- Dividend yield
- —
- Beta
- 1.58
WOOF key metrics, FY2016–FY2026
Fiscal year ended January 31, 2026 · U.S. dollarsWOOF valuation Price multiples at each fiscal year-end price.
WOOF returns How much profit the business earns on the capital it uses.
WOOF per-share figures Results divided by the shares outstanding at year-end.
WOOF financial health Debt, liquidity and how easily interest is covered.
WOOF efficiency & capital use Working capital cycle and where the cash goes.
WOOF valuation history
WOOF returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
WOOF debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
WOOF cash returned to shareholders
WOOF price vs earnings per share
WOOF key metrics
FY2016–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $769.7M | $935.1M | $639.4M | $3.11B | $4.98B | $5.48B | — | — | — | — |
| Enterprise value | $3.37B | $3.73B | $3.56B | $6.04B | $7.81B | $8.37B | — | — | — | — |
| P/E ratio | 84.9 | — | — | 34.2 | 30.3 | — | — | — | — | — |
| Price / sales | 0.1 | 0.2 | 0.1 | 0.5 | 0.9 | 1.1 | — | — | — | — |
| Price / book | 0.7 | 0.8 | 0.5 | 1.3 | 2.2 | 2.7 | — | — | — | — |
| Price / free cash flow | 4.1 | 18.8 | — | 45.7 | 41.8 | 50.3 | — | — | — | — |
| Price / operating cash flow | 2.5 | 5.3 | 3.0 | 9.0 | 13.9 | 20.4 | — | — | — | — |
| EV / sales | 0.6 | 0.6 | 0.6 | 1.0 | 1.3 | 1.7 | — | — | — | — |
| EV / EBITDA | 9.8 | 17.3 | — | 14.8 | 17.3 | 23.8 | — | — | — | — |
| EV / free cash flow | 18.0 | 75.0 | — | 88.8 | 65.6 | 76.8 | — | — | — | — |
| Earnings yield | 1.2% | −10.9% | −200.2% | 2.9% | 3.3% | −0.5% | — | — | — | — |
| Free cash flow yield | 24.3% | 5.3% | −1.5% | 2.2% | 2.4% | 2.0% | — | — | — | — |
| Dividend yield | — | — | — | 0.4% | 0.0% | 8.7% | — | — | — | — |
| Shareholder yield (dividends + buybacks) | — | 0.7% | 1.4% | 0.9% | 0.0% | 8.7% | — | — | — | — |
| Share price at fiscal year-end | $2.69 | $3.42 | $2.39 | $11.69 | $18.75 | $26.03 | — | — | — | — |
| Per share | ||||||||||
| Revenue per share | $20.83 | $22.37 | $23.38 | $22.70 | $21.89 | $23.35 | — | — | $30.80 | $25.89 |
| Earnings per share | $0.03 | −$0.37 | −$4.78 | $0.34 | $0.62 | −$0.13 | — | — | $2.66 | $2.62 |
| Operating cash flow per share | $1.10 | $0.65 | $0.81 | $1.30 | $1.35 | $1.27 | — | — | $4.77 | $3.85 |
| Free cash flow per share | $0.65 | $0.18 | −$0.04 | $0.26 | $0.45 | $0.52 | — | — | $3.27 | $2.70 |
| Cash per share | $0.90 | $0.61 | $0.47 | $0.76 | $0.80 | $0.53 | — | — | $1.00 | $1.20 |
| Book value per share | $4.07 | $4.07 | $4.43 | $8.95 | $8.57 | $9.82 | — | — | $18.00 | $15.11 |
| Tangible book value per share | −$2.94 | −$3.26 | −$3.07 | −$3.15 | −$3.52 | −$5.39 | — | — | −$11.08 | −$4.49 |
| Dividends per share | — | — | — | $0.04 | $0.00 | $2.26 | — | — | — | — |
| Capex per share | $0.44 | $0.47 | $0.84 | $1.05 | $0.90 | $0.76 | — | — | $1.50 | $1.16 |
| Debt per share | $10.00 | $10.82 | $11.38 | $11.78 | $11.49 | $14.25 | — | — | $16.49 | $10.59 |
| Shares outstanding | 286.1M | 273.4M | 267.5M | 266.0M | 265.3M | 210.7M | — | — | 81.7M | 82.4M |
| Change in shares outstanding | +4.7% | +2.2% | +0.6% | +0.2% | +25.9% | — | — | — | −0.8% | −6.2% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 0.8% | −8.9% | −71.8% | 3.9% | 7.6% | −2.0% | −15.9% | −39.2% | 16.0% | 17.7% |
| Return on invested capital (ROIC) | 1.9% | 0.1% | −19.8% | 3.1% | 4.0% | 3.0% | 2.0% | −5.3% | 9.8% | 11.5% |
| Return on assets (ROA) | 0.2% | −1.9% | −21.4% | 1.4% | 2.6% | −0.4% | −1.7% | −10.0% | 7.4% | 8.9% |
| Return on tangible assets | 0.3% | −3.2% | −38.1% | 2.7% | 5.0% | −0.9% | −3.3% | −26.3% | 21.8% | 24.2% |
| Free cash flow margin | 3.1% | 0.8% | −0.2% | 1.1% | 2.1% | 2.2% | −1.1% | 1.2% | 10.6% | 10.4% |
| Income quality (OCF / net income) | 34.64 | — | — | 3.81 | 2.18 | — | — | — | 1.79 | 1.47 |
| Financial health | ||||||||||
| Total debt | $2.86B | $2.96B | $3.04B | $3.13B | $3.05B | $3.00B | $4.69B | $3.23B | $1.35B | $872.5M |
| Cash & short-term investments | $256.7M | $165.8M | $125.4M | $201.9M | $211.6M | $111.4M | $148.8M | $180.6M | $81.4M | $98.9M |
| Net debt | $2.60B | $2.79B | $2.92B | $2.93B | $2.84B | $2.89B | $4.54B | $3.05B | $1.27B | $773.6M |
| Debt / equity | 2.46 | 2.66 | 2.57 | 1.32 | 1.34 | 1.45 | 8.24 | 5.06 | 0.92 | 0.70 |
| Debt / assets | 0.55 | 0.57 | 0.57 | 0.47 | 0.47 | 0.49 | 0.76 | 0.66 | 0.40 | 0.35 |
| Net debt / EBITDA | 7.59 | 12.97 | — | 7.19 | 6.27 | 8.20 | 15.97 | — | 2.62 | 1.71 |
| Current ratio | 0.90 | 0.85 | 0.86 | 0.99 | 1.02 | 0.89 | 0.84 | 1.40 | 0.95 | 1.21 |
| Quick ratio | 0.38 | 0.28 | 0.24 | 0.36 | 0.38 | 0.27 | 0.28 | 0.54 | 0.75 | 0.99 |
| Interest coverage | 0.9 | 0.0 | -7.8 | 2.2 | 3.4 | 0.9 | 0.4 | -0.9 | 11.5 | 17.3 |
| Working capital | −$114.4M | −$165.5M | −$161.4M | −$5.3M | $17.6M | −$97.8M | −$130.9M | $218.1M | −$15.4M | $49.9M |
| Invested capital | $3.77B | $3.91B | $4.10B | $5.31B | $5.11B | $4.96B | $5.11B | $3.68B | $2.74B | $2.02B |
| Tangible asset value | −$840.8M | −$891.4M | −$820.9M | −$837.5M | −$953.2M | −$1.15B | −$2.65B | −$2.71B | −$905.8M | −$370.1M |
| Net current asset value | −$2.99B | −$3.11B | −$3.23B | −$3.22B | −$3.17B | −$3.24B | −$4.88B | −$3.52B | −$1.62B | −$980.1M |
| Graham number | $1.70 | — | — | $8.29 | $10.93 | — | — | — | $32.83 | $29.85 |
| Graham net-net per share | −$11.96 | −$13.01 | −$13.75 | −$13.78 | −$13.76 | −$17.13 | — | — | −$21.14 | −$13.11 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | $11.8M | $308,000 | $476.0M | — | — | — | — |
| Share buybacks (net) | — | $6.3M | $8.7M | $15.6M | $33,000 | $105,000 | $0 | $111,000 | $17.2M | $165.6M |
| Dividend payout ratio | — | — | — | 13.0% | 0.2% | — | — | — | — | — |
| Dividends + buybacks / free cash flow | — | 12.7% | — | 40.2% | 0.3% | 436.6% | — | 0.2% | 6.5% | 74.5% |
| Capex / revenue | 2.1% | 2.1% | 3.6% | 4.6% | 4.1% | 3.2% | 3.5% | 3.4% | 4.9% | 4.5% |
| Capex / operating cash flow | 40.5% | 72.0% | 104.6% | 80.4% | 66.8% | 59.4% | 142.6% | 73.0% | 31.5% | 30.0% |
| Capex / depreciation | 0.65 | 0.64 | 1.12 | 1.43 | 1.39 | 0.91 | 0.91 | 0.79 | 1.18 | 1.14 |
| Stock-based compensation / revenue | 0.5% | 0.8% | 1.3% | 1.0% | 0.8% | 0.3% | 0.2% | 0.2% | 0.7% | 0.8% |
| SG&A / revenue | 36.6% | 37.9% | 37.0% | 36.5% | 37.2% | 38.9% | 40.1% | 39.3% | 8.1% | 8.6% |
| Efficiency | ||||||||||
| Days sales outstanding | 2.6 | 2.5 | 2.7 | 3.2 | 3.1 | 2.7 | 2.4 | 4.7 | 11.8 | 11.7 |
| Days of inventory on hand | 62.1 | 64.4 | 62.5 | 67.1 | 65.5 | 66.0 | 68.5 | 38.7 | 10.3 | 12.1 |
| Days payables outstanding | 47.1 | 47.1 | 40.5 | 39.7 | 40.1 | 41.0 | 41.2 | 25.4 | 11.5 | 11.1 |
| Cash conversion cycle (days) | 17.6 | 19.8 | 24.8 | 30.6 | 28.5 | 27.7 | 29.8 | 18.1 | 10.6 | 12.7 |
| Receivables turnover | 138.26 | 144.27 | 133.16 | 114.75 | 119.19 | 134.17 | 149.32 | 77.41 | 31.03 | 31.12 |
| Payables turnover | 7.75 | 7.75 | 9.01 | 9.19 | 9.09 | 8.89 | 8.87 | 14.40 | 31.83 | 32.93 |
| Inventory turnover | 5.88 | 5.67 | 5.84 | 5.44 | 5.57 | 5.53 | 5.33 | 9.43 | 35.28 | 30.19 |
| Asset turnover | 1.15 | 1.16 | 1.04 | 0.92 | 0.92 | 0.80 | 0.80 | 1.06 | 0.86 | 0.88 |
| Average receivables | $43.1M | $42.4M | $47.0M | $52.6M | $48.7M | $36.7M | $29.7M | $56.7M | $81.1M | $68.6M |
| Average payables | $471.7M | $489.0M | $433.2M | $392.6M | $371.7M | $316.3M | $285.1M | $172.8M | $60.5M | $49.3M |
| Average inventory | $621.8M | $668.9M | $668.5M | $663.8M | $606.9M | $508.8M | $474.6M | $263.9M | $54.6M | $53.8M |
| Intangibles / total assets | 38.8% | 38.6% | 37.4% | 48.7% | 49.4% | 52.7% | 52.1% | 68.0% | 70.5% | 64.4% |
Computed from WOOF's annual financial statements (latest annual report filed March 13, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
WOOF valuation and financial ratios
At the end of fiscal 2026 (January 31, 2026), Petco Health and Wellness traded at 84.9 times earnings, against a 10-year median of 34.2. Based on the latest twelve months, the trailing P/E is 23.3 and the forward P/E is 7.0. Petco Health and Wellness earned a return on equity of 0.8% and a return on invested capital of 1.9% in fiscal 2026. It ended the year with $2.9 billion of debt and $256.7 million in cash and short-term investments, net debt of $2.6 billion. The share count rose 247.2% from 82.4M to 286.1M over 9 years.
See the WOOF income statement, the WOOF chart for price history, or the WOOF stock overview for the latest quote and news.
WOOF key metrics FAQ
What is Petco Health and Wellness's P/E ratio?
Petco Health and Wellness's trailing P/E ratio is 23.3 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 7.0. At the end of fiscal 2026 it was 84.9, compared with a 10-year median of 34.2.
What is Petco Health and Wellness's EV/EBITDA?
Petco Health and Wellness's enterprise value was 9.8 times EBITDA at the end of fiscal 2026 (enterprise value $3.4 billion, EBITDA $343.2 million); the current EV/EBITDA is 9.8.
What is Petco Health and Wellness's return on equity?
Petco Health and Wellness's return on equity (ROE) was 0.8% in fiscal 2026: net income of $9.1 million on average shareholders' equity of $1.1 billion.
What is Petco Health and Wellness's ROIC?
Petco Health and Wellness's return on invested capital was 1.9% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Petco Health and Wellness have?
Petco Health and Wellness had total debt of $2.9 billion at the end of fiscal 2026, a debt-to-equity ratio of 2.46 and $2.6 billion of net debt (7.59 times EBITDA).
What is Petco Health and Wellness's free cash flow yield?
Petco Health and Wellness generated $187.0 million of free cash flow in fiscal 2026, a free cash flow yield of 24.3% on its market value at year-end ($769.7 million).
What is Petco Health and Wellness's current ratio?
Petco Health and Wellness's current ratio was 0.90 at the end of fiscal 2026: current assets were 0.90 times current liabilities.